Drug Interaction Report

Sertraline and Apalutamide: Interaction Details

AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Apalutamide

Erleada
+

Sertraline

No brand names on record
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Jul 2, 2026
LinkedIn
Interaction severity
Major
Potentially serious — often needs a change or close monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 532 documented Sertraline interactions, 477 are rated major — including this one.
Worried about symptoms right now? Contact your pharmacist or prescriber, or call Poison Control at 1-800-222-1222 (US). Call 911 for an emergency.
At a glance + Effects may be weaker
The Bottom Line
Apalutamide speeds up the breakdown of sertraline, which can weaken its effect, so watch for returning depression or anxiety symptoms and let your care team adjust the dose or choose an alternative.

Here's what's going on. Apalutamide (Erleada) is a strong "enzyme booster." It speeds up a liver enzyme called CYP3A4, which is one of the pathways your body uses to break down sertraline. When that pathway runs faster, sertraline can get cleared out of your body more quickly. That means there may be less sertraline working for you, and your depression or anxiety symptoms could creep back.

The good news is this is very manageable. Please don't change anything on your own. Your care team can watch how you're feeling, adjust your dose if needed, or pick a different antidepressant that isn't affected. Just keep taking both as prescribed and mention any return of symptoms.

Effect: Reduced exposure of the CYP3A4 substrate (sertraline) via apalutamide-mediated CYP3A4 induction. Neither drug is a prodrug, so faster metabolism means lower sertraline plasma levels and potential loss of antidepressant efficacy.

  • Direction: Decreased sertraline exposure (AUC/Cmax), risk of therapeutic failure.
  • Onset: Unspecified; enzyme induction typically develops over 1 to 2 weeks and persists during therapy.
  • Evidence: Probable; apalutamide is a potent CYP3A4 inducer (midazolam data support).
  • Management: Consider an antidepressant less dependent on CYP3A4. If continued, monitor for loss of efficacy and titrate dose per clinical response.
Onset
unspecified
Evidence
probable
Severity
Major

What happens

Reduced CYP3A4 substrate exposure

Interaction Deep Dive

Taking apalutamide alongside CYP3A4 substrates can lower the exposure of those substrates. In clinical studies, giving apalutamide together with midazolam (a CYP3A4 substrate) led to reduced apalutamide exposure. During apalutamide treatment, it is advised to replace any drug that relies mainly on CYP3A4 for its metabolism. When coadministration cannot be avoided, monitor the patient for diminished substrate activity1.

Why it happens (mechanism)

Induction of CYP3A4-mediated metabolism by apalutamide

How to manage this interaction

The key point: apalutamide can lower how much sertraline is active in your body, so your antidepressant may work less well.

What your care team may do:

  • Consider switching to an antidepressant that apalutamide affects less.
  • If you stay on both, watch closely for a return of depression or anxiety symptoms.
  • Adjust your sertraline dose as needed, individualized to how you respond.

What you can do: keep taking both exactly as prescribed, and tell your pharmacist or prescriber if your mood, sleep, energy, or anxiety symptoms return. Don't stop or change doses on your own.

Management is individual — confirm any change with your pharmacist or prescriber.

Literature reports

1 report — tap to read

a) Giving a single dose of apalutamide together with midazolam, a CYP3A4 substrate, produced a 92% reduction in the AUC of midazolam 1.

Common questions

Can I take Sertraline and Apalutamide together?

Apalutamide speeds up the breakdown of sertraline, which can weaken its effect, so watch for returning depression or anxiety symptoms and let your care team adjust the dose or choose an alternative. Always confirm with your pharmacist or prescriber before making any change.

How serious is the Sertraline and Apalutamide interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How is the Sertraline and Apalutamide interaction managed?

The key point: apalutamide can lower how much sertraline is active in your body, so your antidepressant may work less well. What your care team may do: Consider switching to an antidepressant that apalutamide affects less. If you stay on both, watch closely for a return of depression or anxiety symptoms. Adjust your sertraline dose as needed, individualized to how you respond. What you can do: kee… Management is individual — always follow your own care team's guidance.

How strong is the evidence for this interaction?

The evidence is graded "probable". Good supporting evidence, though not definitively proven.

Questions for your pharmacist

  • Does my dose of Sertraline or Apalutamide need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there a safer alternative to one of these medications for me?

References (1)

  1. Product Information: ERLEADA(R) oral tablets, apalutamide oral tablets. Janssen Products LP (per FDA), Horsham, PA, 2024. DailyMed
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.